Repligen | RGEN - Ebit

金融业

USD

USD 2.93B

现金及等价物

USD 582.65M

USD 85.97M

USD 1.16B

USD 126.21M

USD 546.59M

USD 19.98M

USD 40.01M

1.78K

EPS每股收益

USD 0.48

股本和储备

USD 2.11B

USD 108.28M

债务利息支出

USD 5.58M

USD 7.31M

USD 546.59M

USD 7.36B

USD 8.33M

USD 174.27M

USD 19.98M

普通股股本

USD 56.4M

109.48

USD 19.11M

USD 194M

销售和管理费用

USD 76.54M

USD 179.26M

贸易债权人

USD 34.66M

应收帐款人

USD 151.55M

	Ebit	更改		日
Agilent	USD 399M		46M	2026-03
Align Technology	USD 178.05M		46.66M	2026-03
Bio Techne	USD 75.49M		21.03M	2026-03
BioMarin Pharmaceutical	USD 129.65M		68.74M	2026-03
Bristol-Myers Squibb	USD 3.56B		90M	2026-03
Bruker	USD 10.2M		66.1M	2026-03
Charles River Laboratories	USD 119.9M		44.08M	2026-03
Danaher	USD 1.34B		158M	2026-03
Dentsply International	USD 32M		506M	2026-03
General Electric Aerospace	USD 2.09B		416M	2026-03
Henry Schein	USD 194M		8M	2026-03
Illumina	USD 239M		17M	2026-03
IQVIA Holdings	USD 565M		2.11B	2026-03
Mettler Toledo International	USD 233.93M		118M	2026-03
Myriad Genetics	USD -3M		20.3M	2025-12
OraSure Technologies	USD -13.59M		2.13M	2025-12
Pacific Biosciences Of California	USD -53.19M		35.08M	2025-12
Pfizer	USD 4.99B		340M	2026-03
Repligen	USD 19.98M		13K	2026-03
Revvity	USD 82.77M		63.06M	2026-03
Standard Biotools	USD -21.92M		10.97M	2025-12
Thermo Fisher Scientific	USD 1.91B		389M	2026-03
Waters	USD 148M		122.52M	2026-03
West Pharmaceutical Services	USD 177.1M		14.6M	2026-03